Habahab, Marbe Ann A.
HRN: 21-84-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2023
CEFUROXIME 500MG (TAB)
05/24/2023
05/30/2023
PO
500mg
BID
UTI
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes